KPTN

KPTN (kaptin) is an actin-binding protein that functions as an essential subunit of the lysosomal KICSTOR complex, where it serves as a negative regulator of mTORC1 signaling controlling neuronal growth and cortical positioning (PMID:37437211, PMID:41401028). It was first defined biochemically as an F-actin-binding protein that localizes to dynamic actin structures including platelet leading edges, fibroblast lamellipodia, and the barbed-end actin-polymerization sites at stereocilia tips, with actin association required for normal neuromorphogenesis (PMID:10099934, PMID:24239382). Within KICSTOR (KPTN, ITFG2, C12orf66, SZT2), KPTN enables recruitment of the GATOR1 complex (DEPDC5, NPRL2, NPRL3) to the lysosomal surface, thereby restraining mTORC1; loss of KPTN produces rapamycin-sensitive mTORC1 hyperactivation (PMID:37437211, PMID:41401028). KICSTOR integrity is set by competing ubiquitination events: FBXO2 binds KPTN through its F-box-associated domain and catalyzes K48/K63-linked polyubiquitination at K49, K67, K262, and K265, disrupting KPTN's interactions with ITFG2 and SZT2 and impairing GATOR1 recruitment to activate mTORC1, while OTUD3 reverses non-degradative ubiquitination at K49 to suppress mTORC1 and promote GATOR1 lysosomal localization (PMID:38288086, PMID:41401028). Consistent with this regulatory role, KPTN loss-of-function causes mTOR-dependent phenotypes including increased cell size, cellular aggregation, and heterotopic neurons in the cortex, underlying a neurodevelopmental disorder with macrocephaly and cortical dyslamination (PMID:24239382, PMID:41696790).

1. 1999 Medium

   Established the first molecular identity of KPTN as an actin-binding protein, defining where it acts in the cell before any signaling role was known.

   Evidence F-actin affinity chromatography with ATP elution plus immunofluorescence in platelets, fibroblasts, and inner ear epithelium

   PMID:10099934

   Open questions at the time

   • No mutagenesis to map the actin-binding interface
   • Functional consequence of actin binding not tested
   • No link to a signaling pathway
2. 2000 Low

   Refined KPTN's actin localization to the barbed-end polymerization site at stereocilia tips, implying a role at sites of active filament elongation.

   Evidence Double-label immunofluorescence with F-actin markers in inner ear sensory epithelium

   PMID:11409409

   Open questions at the time

   • Single localization method, no functional validation
   • Mechanism of barbed-end targeting unknown
3. 2013 Medium

   Connected KPTN actin association to human disease, showing patient mutations abolish actin localization and impair neuromorphogenesis.

   Evidence Immunofluorescence of endogenous and GFP-tagged kaptin in primary neurons with patient-derived mutant constructs

   PMID:24239382

   Open questions at the time

   • Did not establish the downstream signaling mechanism
   • Single lab, no reconstitution
   • Causal chain from actin mislocalization to neuronal phenotype unresolved
4. 2023 High

   Placed KPTN within the KICSTOR complex as a negative regulator of mTORC1, reframing the disease as an mTOR signalopathy.

   Evidence Mouse Kptn knockout and human iPSC models with mTORC1 biochemical readouts and rapamycin rescue

   PMID:37437211

   Open questions at the time

   • Did not resolve how KPTN loss is sensed at the lysosome
   • Relationship between actin function and mTOR role unclear
5. 2024 Medium

   Identified post-translational control of KPTN, showing OTUD3 deubiquitinates KPTN at K49 to suppress mTORC1 and promote GATOR1 lysosomal localization.

   Evidence In vivo ubiquitination assay, Co-IP, OTUD3 CRISPR knockout, GATOR1 localization imaging, NMR

   PMID:38288086

   Open questions at the time

   • The opposing ubiquitin ligase was not identified in this study
   • Single lab
   • Stoichiometry and dynamics of the modification unresolved
6. 2025 High

   Identified FBXO2 as the ligase that ubiquitinates KPTN and resolved the mechanism by which this modification dismantles KICSTOR to activate mTORC1.

   Evidence Co-IP, in vitro ubiquitination with linkage typing, F-box-associated domain mutagenesis, KICSTOR subunit interaction and lysosomal recruitment assays

   PMID:41401028

   Open questions at the time

   • Upstream signals controlling FBXO2 activity not defined
   • Interplay between FBXO2 and OTUD3 not quantified
   • In vivo relevance of specific lysine sites not tested
7. 2025 Medium

   Demonstrated that acute KPTN loss drives mTOR-dependent cellular aggregation, linking the signaling defect to a phenotype relevant to cortical dyslamination.

   Evidence CRISPR knockout in N2a cells, pS6 Western blot, live-cell imaging, rapamycin rescue, LC-MS/MS (preprint)

   PMID:bio_10.1101_2025.11.02.685388

   Open questions at the time

   • Preprint, not peer-reviewed
   • Aggregation mechanism downstream of mTOR not defined
   • In vitro cell line system
8. 2026 Medium

   Established a cell-autonomous, mTOR-dependent role for KPTN in cortical neuronal positioning in vivo.

   Evidence In utero electroporation focal Kptn KO in mouse cortex, histology, cell size assays, rapamycin treatment of Kptn-/- mice

   PMID:41696790

   Open questions at the time

   • Molecular link between mTOR hyperactivation and migration defect unresolved
   • Single study
   • Contribution of actin-binding function to migration not separated from mTOR role

• It remains unresolved how KPTN's original actin-binding function mechanistically relates to its KICSTOR/mTORC1 regulatory role, and what physiological signals coordinate FBXO2 and OTUD3 to set KICSTOR integrity.
• No experiment unifies the actin and mTOR functions
• Upstream regulators of the ubiquitination switch unknown
• No structural model of KPTN within KICSTOR